Hjem › Type 1-diabetes › Washington › Seattle
Kliniske studier for Type 1-diabetes i Seattle, WA
18 studier for Type 1-diabetes søker deltakere på steder i og rundt Seattle (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Type 1 Diabetes Extension Study
RekruttererObservasjonsstudie
- Benaroya Research Institute, Seattle
METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)
RekruttererFase 2
- University of Washington Medicine Diabetes Institute (UWMDI), Seattle
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
RekruttererFase 3
- Benaroya Research Institute at Virginia Mason- Site Number : 8400038, Seattle
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
RekruttererFase 1/2
- Benaroya Research Institute, Seattle
- University of Washington Diabetes Institute, Seattle
Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG
RekruttererFase 2
- Benaroya Research Institute, Seattle
Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
RekruttererFase 2
- Benaroya Research Institute, Seattle
A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
RekruttererFase 1/2
- Seattle Children's Hospital, Seattle
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
RekruttererFase 2
- Benaroya Research Institute at Virginia Mason, Seattle
Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery
Rekrutterer
- University of Washington, Seattle
Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes
RekruttererFase 2
- University of Washington, Seattle
Kidney Precision Medicine Project
RekruttererObservasjonsstudie
- University of Washington, Seattle
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
RekruttererFase 3
- University of Washington, Seattle
Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes
RekruttererFase 3
- University of Washington Medicine Diabetes Institute (UWMDI), Seattle
Achieving Health in Emerging Adults With Diabetes (AHEAD) Program: A Clinical Trial Designed to Understand if Participation in a Clinical Program Developed Specifically to Support Emerging Adults With Type 1 Diabetes Leads to Improved Diabetes Outcomes.
Rekrutterer
- Seattle Children's, Seattle
EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study)
RekruttererObservasjonsstudie
- Benaroya Research Institute, Seattle
InvesT1D: Promoting Adolescent Investment in Diabetes Care
Rekrutterer
- Seattle Children's, Seattle
TrialNet Pathway to Prevention of T1D
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Benaroya Research Institute, Seattle
MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
RekruttererFase 1
- Seattle Children's Hospital, Seattle
Type 1-diabetes-studier i andre byer
- Aurora, CO23 studier
- Boston, MA21 studier
- Chicago, IL16 studier
- New Haven, CT15 studier
- New York City, NY15 studier
- Indianapolis, IN14 studier
- San Francisco, CA14 studier
- Miami, FL13 studier
- Gainesville, FL12 studier
- Philadelphia, PA11 studier
- Atlanta, GA11 studier
- Durham, NC10 studier
Andre studier i Seattle
- Ikke-småcellet lungekreft53 studier
- Kreft (alle typer)49 studier
- Prostatakreft42 studier
- Akut myelogen leukemi40 studier
- Brystkreft39 studier
- Metastatisk kreft39 studier
- Kolorektal kreft34 studier
- Lungekreft33 studier
- Eggstokkreft30 studier
- Multipelt myelom22 studier
- Myelodysplastiske syndromer21 studier
- Akut lymfoblastisk leukemi21 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.